Indication

Small lymphocytic lymphoma

Small lymphocytic lymphoma is an indolent non-Hodgkin lymphoma characterized by the clonal proliferation and tissue accumulation of immunologically mature, monoclonal B lymphocytes. Read more about Small lymphocytic lymphoma

26 drugs 18 manufacturers

Advertisement

Drugs that treat it

Common Small lymphocytic lymphoma therapies.

Showing 10–18 of 26 drugs

COPIKTRA (duvelisib)

ANTINEOPLASTIC - PHOSPHATIDYLINOSITOL 3-KINASE DELTA INHIB.·CHRONIC LYMPHOCYTIC LEUKEMIA·+1
VERASTEM, INC.

BRUKINSA (zanubrutinib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·CHRONIC LYMPHOCYTIC LEUKEMIA·+5
BEONE MEDICINES

COPIKTRA (duvelisib)

ANTINEOPLASTIC - PHOSPHATIDYLINOSITOL 3-KINASE DELTA INHIB.·CHRONIC LYMPHOCYTIC LEUKEMIA·+1
SECURA BIO, INC
Filter & compare in the drug finder →Opens the drug finder with Small lymphocytic lymphoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Small lymphocytic lymphoma.

Small lymphocytic lymphoma is an indolent non-Hodgkin lymphoma characterized by the clonal proliferation and tissue accumulation of immunologically mature, monoclonal B lymphocytes.

It predominantly affects the lymphatic system in older adults, presenting primarily as painless lymphadenopathy and splenomegaly.

Pathophysiologically identical to chronic lymphocytic leukemia, it is distinguished clinically by disease confinement largely to the lymph nodes and spleen, with peripheral monoclonal B-cell counts remaining below 5 × 10?/L.

Personalize your experience

Follow Small lymphocytic lymphoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it